They proposed that circSMARCA5 could affect the ratio of the pro- to anti-angiogenic VEGFA isoforms in GBM, and could be a prognostic bio-marker for anti-angiogenesis treatment (Barbagallo et al., 2019). Here, VEGFA is linked to glioblastoma.